Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual ...
Zhengye Biotechnology announces full exercise of ... The shares began trading on the Nasdaq Capital Market under the ticker symbol "ZYBT" on January 7, 2025. Funds from the IPO will be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback